Skip to main content
Equibles

Rockefeller Capital Management L.P.

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1739439 NEW YORK, NY
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$154
+$18 QoQ
Shares Held
33
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 89 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $308,249,937 across 242 Biotechnology names. XFOR ranks #227 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 149,476 $74,249,211
2 JAZZ
Jazz Pharmaceuticals plc
 167,409 $40,340,545
3 ACAD
Acadia Pharmaceuticals Inc
 1,015,420 $25,690,124
4 BMRN
Biomarin Pharmaceutical Inc
 433,376 $24,797,774
5 PTCT
Ptc Therapeutics, Inc.
 302,393 $24,666,195
6 MDGL
Madrigal Pharmaceuticals, Inc.
 29,015 $15,579,603
7 REGN
Regeneron Pharmaceuticals, Inc.
 21,563 $13,445,391
8 CORT
Corcept Therapeutics Inc
 123,388 $10,728,585

All Filings in XFOR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $154 33
2026-03-31 $136 33
2025-12-31 $132 33
2025-09-30 $112 33
2022-12-31 $992 1,000
2022-09-30 $1,709 1,000
2022-06-30 $964 1,000
2022-03-31 $1,749 1,000
2021-12-31 $2,289 1,000